KFDA to probe fake anti-obesity drugs

The Korea Food and Drug Administration has embarked on looking into false and exaggerated advertisements of the country's anti-obesity drugs following its administrative dispositions against Huons, Kwangdong and Doctors MediLine.

The KFDA indicated on April 4 that the health watchdog will scrutinize the country's anti-obesity drug manufacturers in relation to their false and exaggerated adve...